2022
DOI: 10.3389/fnagi.2022.838803
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Dopamine 4 Receptor Subtype Enhances Gamma Oscillations in Hippocampal Slices of Aged Mice

Abstract: AimNeural network oscillation at gamma frequency band (γ oscillation, 30–80 Hz) is synchronized synaptic potentials important for higher brain processes and altered in normal aging. Recent studies indicate that activation of dopamine 4 receptor (DR4) enhanced hippocampal γ oscillation of young mice and fully recovered the impaired hippocampal synaptic plasticity of aged mice, we determined whether this receptor is involved in aging-related modulation of hippocampal γ oscillation.MethodsWe recorded γ oscillatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…Dopaminergic neurons in the VTA were shown to synchronize with substantial fractions of these cells at both delta and theta frequencies and gamma rhythm in the VTA was also modulated by delta rhythm in VTA and PFC and by the phase-coupled theta in HPC [ 21 ]. D4R agonists in high doses elicit aberrant gamma oscillations [ 28 ] comparable with that reported after administration of ketamine or other NMDA-R agonists [ 29 ]. Interestingly, ketamine’s action on gamma oscillation is at least partially depended on D4R in the thalamus but not in the PFC [ 29 ].…”
Section: Introductionmentioning
confidence: 63%
“…Dopaminergic neurons in the VTA were shown to synchronize with substantial fractions of these cells at both delta and theta frequencies and gamma rhythm in the VTA was also modulated by delta rhythm in VTA and PFC and by the phase-coupled theta in HPC [ 21 ]. D4R agonists in high doses elicit aberrant gamma oscillations [ 28 ] comparable with that reported after administration of ketamine or other NMDA-R agonists [ 29 ]. Interestingly, ketamine’s action on gamma oscillation is at least partially depended on D4R in the thalamus but not in the PFC [ 29 ].…”
Section: Introductionmentioning
confidence: 63%
“…Furthermore, as D4Rs localized on both pyramidal and GABAergic neurons in the cortex, hippocampus, thalamus, globus pallidus , and substantia nigra [ 60 ], it has been hypothesized that selective D4R antagonists could, directly and indirectly, modulate glutamatergic transmission [ 60 ]. D4R seems to also be involved in the restoration of γ-oscillation in the hippocampal slices of aged mice brains, probably with a therapeutic effect on cognitive impairment related to ageing [ 61 ]. This effect is reported in hippocampal parvalbumin-positive GABA interneurons and parvalbumin-positive basket cells, which are critical for γ-oscillations, by double in situ hybridization and immunofluorescence histochemistry, confirming the crucial role of D4R in cognitive deficits [ 62 ].…”
Section: Resultsmentioning
confidence: 99%
“…The sources of drugs were: D4R agonist PD168077 (Tocris Bioscience, 1065/10) and antagonist L-745,870 (Tocris Bioscience, 1002/10) (43,44); NCC inhibitor metolazone (Met) (MedChemExpress, HY-B0209); Hydrochlorothiazide (HCTZ) (Sigma, H2910); Cycloheximide (CHX) (MedChemExpress, HY-12320); Chloroquine (CQ) (MedChemExpress, HY-17589A). The rabbit polyclonal D4R and chicken polyclonal NCC antibodies were generated and affinity-purified in our laboratory.…”
Section: Drugs and Antibodiesmentioning
confidence: 99%